Patents by Inventor Isabelle Elias

Isabelle Elias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7442519
    Abstract: The invention encompasses polypeptides and polynucleotides of three novel bipolar disorder-associated potassium channel polypeptides, KCNQ2-15bx, KCNQ2-15by and KCNQ2-15bz. The invention further relates to the use of potassium channels comprising KCNQ2 subunits for screening for modulators thereof, the use of these modulators for treating mental disorders such as bipolar disorder, schizophrenia and depression, and drugs comprising these modulators. The invention also discloses biallelic markers located in the KCNQ2 gene and their use for diagnosing mental disorders.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: October 28, 2008
    Assignee: Serono Genetics Institute, S.A.
    Inventors: Laurent Cavarec, Ilya Chumakov, Benoit Destenaves, Catherine Gonthier, Isabelle Elias
  • Publication number: 20060099210
    Abstract: The invention encompasses polypeptides and polynucleotides of three novel bipolar disorder-associated potassium channel polypeptides, KCNQ2-15bx, KCNQ2-15by and KCNQ2-15bz. The invention further relates to the use of potassium channels comprising KCNQ2 subunits for screening for modulators thereof, the use of these modulators for treating mental disorders such as bipolar disorder, schizophrenia and depression, and drugs comprising these modulators. The invention also discloses biallelic markers located in the KCNQ2 gene and their use for diagnosing mental disorders.
    Type: Application
    Filed: June 20, 2003
    Publication date: May 11, 2006
    Applicant: Serono Genetics Institute S. A.
    Inventors: Laurent Cavarec, Ilya Chumakov, Benoit Destenaves, Catherine Gonthier, Isabelle Elias